Disease progression model of pancreatic cancer developed by Penn researchers
Building on previous work, researchers at the University of Pennsylvania School of Medicine have developed an animal model of pancreatic cancer that closely mimics disease progression in humans. From this, they hope to develop new treatments for this deadly disease. Advanced pancreatic cancer is among the most lethal of cancers, with a one-year survival rate after chemotherapy of only 17 to 28 pe...New imaging technology shown to detect pancreatic inflammation in type 1 diabetes
A key obstacle to early detection of type 1 diabetes - as well as to rapid assessment of the effectiveness of therapeutic intervention - has been the lack of direct, non-invasive technologies to visualize inflammation in the pancreas, an early manifestation of disease. Instead, clinicians have had to await overt symptoms before diagnosing an individual, by which time destruction of the insulin-pr...Gene therapy potential for treatment of pancreatic cancer
A gene responsible for the production of a protein called vasostatin may prove a promising new way of treating pancreatic cancer, suggests research published ahead of print in Gut. Pancreatic cancer is the fifth leading cause of cancer deaths in the developed world, and is extremely difficult to treat. Only 3% of affected patients are still alive five years after diagnosis, a survival rate...Encouraging results in pancreatic cancer research
Researchers at SUNY Downstate Medical Center and the Brooklyn VA Hospital have found that when a human protein, PNC-28, is administered to pancreatic tumor cells in animals, the tumors are destroyed. The research was reported in the October 1st edition of the International Journal of Cancer. Matthew R. Pincus, MD, PhD, professor of pathology at SUNY Downstate and chairman of pathology and...Protein found to shield pancreatic cancer cells from self-destruction
An overexpressed protein protects human pancreatic cancer cells from being forced to devour themselves, removing one of the body's natural defenses against out-of-control cell growth, researchers at The University of Texas M. D. Anderson Cancer Center report in the March issue of Molecular Cancer Research. The protein tissue transglutaminase, known by the abbreviation TG2, previously has b...Canine Pancreatic Microsomal Membranes from Promega
Description:Microsomal vesicles are used to study co-translational and initial post-translational processing of proteins. Processing events such as signal peptide cleavage, membrane insertion, translocation and core glycosylation can be examined by the translation of the appropriate mRNA in vitro in the presence of these microsomal membranes. In addition, processing and glycosylation events may be studied by...Pancreatic Cell Cryopreservation Medium from CHEMICON
Description:Pancreatic Cell Cryopreservation Medium (2X) is intended for the cryopreservation of LT2 Immortalized Pancreatic Mesenchymal Cells (SCR013) and VIT1 Primary Pancreatic Mesenchymal Cells (SCR014)....Dog Anti-Pig Pancreatic Islets of Langerhans Cells Polyclonal Antibody, Unconjugated from Abcam
Description:Dog polyclonal to Porcine Pancreatic Islets of Langerhans Cells ( Tissue / cell preparation (Pig): Sonicated crude membrane fraction of porcine pancreatic islets of langerhans cells....Detection of Mutant K-ras in a Kindred With Hereditary Pancreatic Cancer by DGGE
David A. Crispin,* Ru Chen,* Michael B. Kimmey,** Teresa A. Brentnall** * Departments of Pathology and **Medicine, Division of Gastroenterology, University of Washington, Seattle, Washington. Introduction Pancreatic cancer is the fourth leading cause of cancer death in the U.S....Obesity a risk for pancreatic cancer
A new study reveals that obesity raises the risk of pancreatic cancer, but this can be modified by exercise.Only one person in 20 can expect to live for more than five years after pancreatic cancer has been diagnosed and little has been known about how to prevent it (although smoking is a risk factor). So it's encouraging to learn that you can do something to lower your risk of this h...Gene Therapy Destroys Pancreatic Cancer Cells
Pancreatic cancer is among the deadliest of cancers, affecting many people a year and having an extremely low survival rate. Pancreatic cancer is the most aggressive cancer and there are few palliative treatments. Using a new two-pronged attack, researchers were able to destroy deadly pancreatic cancer cells in the test tube and in lab animals. // The work was led by Dr. Paul B. Fishe...Ulcer Surgery connected to danger of Pancreatic Cancer
A new research suggests that the patients who undergo surgery to remove their ulcers may be at increased risk of later developing pancreatic cancer. The investigators base their findings on an analysis of 2,000 patients who underwent an operation known as gastrectomy to remove their ulcers.// Peptic ulcers are sores located in the lining of the stomach or a portion of the small intesti...Pancreatic Cancer may be linked to Diabetes
According to researchers, a new study strongly propose that diabetes newly diagnosed in people above 50 years, may be a sign of underlying early-stage pancreatic cancer.// Older patients whose diabetes began late in life were 10 times more likely to be diagnosed with pancreatic cancer within three years following onset of diabetes.In the study, the link appeared especially pronounced for people i...Tryptone pancreatic digest of casein
Description:Tryptone is the pancreatic digest of casein used as a nitrogen source for bacteria. Ideal for general bacteriological use with a variety of microorganisms. Tryptone is guaranteed BSE-Free....Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients
PHILADELPHIA, July 3, 2007-- – The appearance of arash in cancer patients treated with erlotinib (Tarceva) isstrongly associated with longer survival, according to researchersfrom the drug’s developer, OSI Pharmaceuticals, Inc. This isnot the first time that rash has been associated with a survivaladvantage with EGFR inhibitors – a class of drugs whichincludes erlotinib...Eurand's Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
Zentase Improves Absorption of Fat, Protein and Other Nutrients inPatients with Mild, Moderate or Severe Malabsorption, WhileControlling Symptoms of Exocrine Pancreatic Insufficiency MILAN, Italy and DAYTON, Ohio, June 19, 2007/PRNewswire-FirstCall/ -- Eurand N.V. today announced results thatwere presented at the recent European Cystic Fibrosis Societymeeting in Antalya, Turkey, held June...Immunomedics Reports Initial Clinical Results With Hpam4 For Pancreatic Cancer Therapy
- Results Presented at Society of Nuclear Medicine Annual Meeting - WASHINGTON, June 05, 2007 /PRNewswire-FirstCall/ --Immunomedics, Inc. , a biopharmaceutical company focused ondeveloping monoclonal antibodies to treat cancer and other seriousdiseases, today announced that initial results from a Phase I studywith the Company's humanized anti-MUC1 monoclonal antibody (hPAM4),labeled with...